abp-745
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 3, 2024 (NCT06258213)
Timeline
Indications
Studied for
Mechanism of action
- Sorbitol dehydrogenaseINHIBITOR
SORD inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07303777 | Phase 2 | Feb 28, 2026 | Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. |
| NCT07145229 | Phase 2 | Aug 26, 2025 | Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. |
| NCT06258213 | Phase 1 | Jan 3, 2024 | Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1